CCWM
CSBR icon

Cassaday & Co Wealth Management’s Champions Oncology CSBR Stock Holding History

Cassaday & Co Wealth Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58 Buy
+10
New +$64 ﹤0.01% 1346

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cassaday & Co Wealth Management's CSBR Position: Q1 2026 in Review

Cassaday & Co Wealth Management opened a new position in Champions Oncology (CSBR) in Q1 2026: 10 shares worth $58. The stake represents ﹤0.01% of the portfolio and ranks #1346 among its holdings.

25 funds tracked by Wall St. Rank hold CSBR as of Q1 2026.

  • Cassaday & Co Wealth Management held 10 shares of Champions Oncology worth $58 as of Q1 2026.
  • Champions Oncology was a new Cassaday & Co Wealth Management position in Q1 2026.
  • Champions Oncology made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q1 2026, its #1346 holding.
  • 25 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.